|
||
 |
||
 |
||
| Dow Pharma Solutions is bringing the brightest and best in the industry together at a special networking event, followed by a dedicated “Solubility Symposium”, on April 26th and 27th 2016 in Zurich, Switzerland. Join us for our pre-event dinner, taking place from 19.00 on Tuesday 26th April at restaurant Giesserei in Zurich. You’ll have chance to meet fellow delegates attending our one-day free Solubility Symposium on Wednesday 27th April, an event designed to share updates on latest generation solutions for oral dose solubility enhancement - including AFFINISOL™ from Dow. Symposium speakers include: - Professor Dr. Henning Blume ̶ SocraTec C&S GmbH - Dr. Uwe Hanenberg ̶ Catalent Pharma Solutions - Dr. Frank Milek ̶ Hedinger - Dirk Leister ̶ Thermo Fisher Scientific - Sarah Nicholson PhD ̶ Bristol-Myers Squibb - João Vicente ̶ Hovione - Kristof Kimpe ̶ Janssen - Dr. Meinolf Brackhagen, Dow Pharma and Food Solutions - Trey Porter, Dow Pharma and Food Solutions The agenda will include presentations and panel discussions on: - The impact of Excipients on the bioavailability of medicinal products - Considerations for Oral Drug Product Dose Form Selection - HPMC and HPMCAS Designed for Hot Melt Extrusion - New regulatory changes for pharmaceutical excipients in Europe - Critical material attribute hunting - Amorphous Formulation Development – from Spray Dried Dispersion to Oral Drug Product - Scale-up of a Hot-Melt Extrusion Process - Spray Dried Amorphous Solid Dispersions: from lab to market - Fundamentals of HPMCAS in Spray Dried Dispersions Interested in new solubility solutions that could help take your products to the next level? Register here for this special event and we will send you joining details. Best regards, Pharma Solutions |
